| abstract |
The invention relates to compounds of formula (I) Its optical isomers and their addition salts with pharmaceutically acceptable acids, where: Ak 1 represents an alkyl chain, X represents-(CH 2 ) m- , -CH (R)-, -N (R )-, -CH 2 -N (R)-, -N (R) -CH 2 -or -CH 2 -N (R) -CH 2- , m and R are as defined in the specification, when X represents-( When CH 2 ) m- , -CH (R)-, -N (R)-, -CH 2 -N (R)-or -N (R) -CH 2- , R 1 and R 2 each represent H, Or when X represents -CH 2 -N (R) -CH 2- , R 1 and R 2 together form a bond, and R 3 represents NH 2 , Cy-NH 2 , Cy-Ak 3 -NH 2 or piperidine-4 -Base, Cy and Ak 3 are as defined in the specification, and R 4 and R 5 (which may be the same or different) each represent H or F. This invention relates to pharmaceuticals. |